Arizona Pain Specialists, PLLC
Arizona Pain Specialists, PLLC was paid $7.55M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoARIZONA PAIN SPECIALISTS, PLLC
SCOTTSDALE, AZ 85258
SCOTTSDALE, AZ 85258
33aNPI1700030939assigned 11/14/2008
33bProvider typeChiropractor
28Total paid$7.55M
24GClaims103,498
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Chiropractor providers in Arizona
Rank by total paid#1 of 35
Median peer was paid$10K
This provider vs. median776×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,160 | $1.52M | |
| 2019 | 12,647 | $957K | |
| 2020 | 12,670 | $1.03M | |
| 2021 | 14,644 | $1.02M | |
| 2022 | 16,528 | $1.24M | |
| 2023 | 12,099 | $830K | |
| 2024incomplete | 14,750 | $956K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 49,483 | 45,385 | $2.84M |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | 12% | 1,236 | 1,186 | $874K |
| 95913 | 7.5% | 2,644 | 2,271 | $566K | |
| 01936 | 7.1% | 5,347 | 4,221 | $539K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.1% | 13,254 | 12,351 | $538K |
| 95886 | 4.7% | 2,747 | 2,325 | $359K | |
| 64483 | 4.4% | 2,681 | 2,210 | $330K | |
| 01992 | 4.0% | 2,715 | 2,118 | $299K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.3% | 2,064 | 1,917 | $175K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 2.3% | 4,221 | 1,541 | $172K |
| 64635 | 2.0% | 623 | 465 | $154K | |
| 64636 | 1.0% | 593 | 438 | $77K |
46 more codes
| 01938 | <1% | 626 | $75K | |
| 62321 | <1% | 363 | $60K | |
| 64493 | <1% | 373 | $56K | |
| 98943 | <1% | 1,359 | $46K | |
| 62323 | <1% | 174 | $39K | |
| 20550 | <1% | 464 | $30K | |
| 01991 | <1% | 368 | $28K | |
| 01940 | <1% | 253 | $27K | |
| 64494 | <1% | 359 | $27K | |
| 27096 | <1% | 141 | $27K | |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 96 | $24K |
| L0180 | Cervical, multiple post collar, occipital/mandibular supports, adjustable | <1% | 90 | $21K |
| 01935 | <1% | 170 | $16K | |
| 20553 | <1% | 301 | $15K | |
| 20611 | <1% | 271 | $14K | |
| 20610 | <1% | 429 | $13K | |
| 64633 | <1% | 70 | $12K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 122 | $9K |
| 90837 | Psychotherapy session, about an hour | <1% | 124 | $9K |
| 01937 | <1% | 105 | $9K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 102 | $8K |
| 97012 | <1% | 479 | $8K | |
| 64490 | <1% | 27 | $7K | |
| 64634 | <1% | 66 | $7K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 102 | $6K |
| L1833 | Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf | <1% | 18 | $5K |
| 64484 | <1% | 112 | $5K | |
| 98940 | <1% | 162 | $5K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,541 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,416 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 38 | $3K |
| 99442 | <1% | 211 | $3K | |
| 64491 | <1% | 13 | $2K | |
| 99443 | <1% | 90 | $2K | |
| 64495 | <1% | 34 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 28 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 13 | $1K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,833 | $751.73 |
| 77002 | <1% | 46 | $584.71 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 26 | $386.08 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 62 | $375.60 |
| 99441 | <1% | 14 | $93.51 | |
| J3490 | Unclassified drugs | <1% | 69 | $86.10 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 56 | $35.40 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 970 | $0.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 104 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOSHIRI, THOMAS (CHIEF BUSINESS OFFICER)